AP833A - 2-Amino-6-(2-substituted-4-phenoxy)-substituted-pyridines. - Google Patents

2-Amino-6-(2-substituted-4-phenoxy)-substituted-pyridines. Download PDF

Info

Publication number
AP833A
AP833A APAP/P/1998/001178A AP9801178A AP833A AP 833 A AP833 A AP 833A AP 9801178 A AP9801178 A AP 9801178A AP 833 A AP833 A AP 833A
Authority
AP
ARIPO
Prior art keywords
alkyl
formula
nmr
nitrogen
disease
Prior art date
Application number
APAP/P/1998/001178A
Other languages
English (en)
Inventor
Iii John Adams Lowe
Jolanta Nowakowski
Robert Alfred Volkmann
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Application granted granted Critical
Publication of AP833A publication Critical patent/AP833A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/73—Unsubstituted amino or imino radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
APAP/P/1998/001178A 1997-02-10 1998-02-05 2-Amino-6-(2-substituted-4-phenoxy)-substituted-pyridines. AP833A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3753397P 1997-02-10 1997-02-10

Publications (1)

Publication Number Publication Date
AP833A true AP833A (en) 2000-05-10

Family

ID=21894849

Family Applications (1)

Application Number Title Priority Date Filing Date
APAP/P/1998/001178A AP833A (en) 1997-02-10 1998-02-05 2-Amino-6-(2-substituted-4-phenoxy)-substituted-pyridines.

Country Status (44)

Country Link
US (2) US20010007873A1 (fr)
EP (1) EP0958282B1 (fr)
JP (1) JP3505189B2 (fr)
KR (1) KR100460399B1 (fr)
CN (3) CN1246848A (fr)
AP (1) AP833A (fr)
AR (1) AR011117A1 (fr)
AT (1) ATE271544T1 (fr)
AU (1) AU744313B2 (fr)
BG (1) BG103633A (fr)
BR (1) BR9811093A (fr)
CA (1) CA2277990C (fr)
CO (1) CO4920225A1 (fr)
CZ (1) CZ292135B6 (fr)
DE (1) DE69825147T2 (fr)
DK (1) DK0958282T3 (fr)
DZ (1) DZ2414A1 (fr)
EA (1) EA003834B1 (fr)
ES (1) ES2224354T3 (fr)
GT (1) GT199800032A (fr)
HN (1) HN1998000030A (fr)
HR (1) HRP980069A2 (fr)
HU (1) HUP0000762A3 (fr)
IL (1) IL130898A0 (fr)
IS (1) IS5118A (fr)
MA (1) MA27676A1 (fr)
MY (1) MY120976A (fr)
NO (1) NO314803B1 (fr)
NZ (2) NZ336623A (fr)
OA (1) OA11084A (fr)
PA (1) PA8446301A1 (fr)
PE (1) PE58599A1 (fr)
PL (1) PL335161A1 (fr)
PT (1) PT958282E (fr)
SI (1) SI0958282T1 (fr)
SK (1) SK101199A3 (fr)
TN (1) TNSN98024A1 (fr)
TR (1) TR199901917T2 (fr)
TW (1) TW458969B (fr)
UA (1) UA64740C2 (fr)
UY (1) UY24881A1 (fr)
WO (1) WO1998034919A1 (fr)
YU (1) YU35699A (fr)
ZA (1) ZA981017B (fr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010049379A1 (en) 1997-08-27 2001-12-06 Lowe John Adams 2-aminopyridines containing fused ring substituents
ES2235475T3 (es) * 1998-06-03 2005-07-01 Pfizer Products Inc. 2-aminopiridinas que contienen sustituyentes de anillos condensados como inhibidores de oxido nitrico sintasa.
EE200100084A (xx) * 1998-08-11 2002-08-15 Pfizer Products Inc. NOS inhibiitorite uued farmatseutilised kasutusv�imalused
SE9803710L (sv) 1998-09-25 2000-03-26 A & Science Invest Ab Användning av vissa substanser för behandling av nervrotsskador
US7115557B2 (en) 1998-09-25 2006-10-03 Sciaticon Ab Use of certain drugs for treating nerve root injury
KR20010114213A (ko) 1999-02-25 2001-12-31 실버스타인 아써 에이. 접합 고리 치환기를 함유한 2-아미노피리딘
FR2812635B1 (fr) * 2000-08-01 2002-10-11 Aventis Pharma Sa Nouveaux composes heterocycliques, preparation et utilisation comme medicaments notamment comme anti- bacteriens
GB0019006D0 (en) * 2000-08-04 2000-09-20 Astrazeneca Ab Novel compounds
US20030045449A1 (en) * 2001-08-15 2003-03-06 Pfizer, Inc. Pharmaceutical combinations for the treatment of neurodegenerative diseases
US20030232739A1 (en) * 2001-08-15 2003-12-18 Pfizer Inc. Pharmaceutical combinations comprising a NOS inhibitor and an NMDA receptor antagonist
DOP2002000467A (es) * 2001-10-10 2003-04-15 Pfizer Prod Inc 2-amino-6 (fenilo sustituido en las posiciones 2,4,5)-piridinas
US6803470B2 (en) 2001-10-10 2004-10-12 Pfizer Inc 2-amino-6-(2,4,5-substituted-phenyl)-pyridines
US7045652B2 (en) * 2002-07-03 2006-05-16 Pfizer Inc Processes for preparing substituted aryl boronic acids
US20040092741A1 (en) * 2002-11-08 2004-05-13 Pfizer Inc Substituted pyridines via boronic acid coupling
WO2005007627A1 (fr) * 2003-07-18 2005-01-27 Nihon Nohyaku Co., Ltd. Derive de phenylpyridine, produit intermediaire correspondant, et herbicide contenant ledit derive de phenylpyridine en tant qu'ingredient actif
CA2598484A1 (fr) * 2005-02-21 2006-08-24 Proximagen Ltd. Inhibition ou traitement de la dyskinesie
GB0607196D0 (en) * 2006-04-11 2006-05-17 Prosidion Ltd G-protein coupled receptor agonists
WO2008080938A1 (fr) * 2006-12-28 2008-07-10 Basf Se Utilisation de pyridines 2-substituées pour traiter le cancer
UA105182C2 (ru) 2008-07-03 2014-04-25 Ньюрексон, Інк. Бензоксазины, бензотиазины и родственные соединения, которые имеют ингибирующую nos активность
CN108017603B (zh) 2013-02-28 2021-07-23 株式会社蒂奥姆生物 三环化合物及其用途
EP3066072B1 (fr) * 2013-11-07 2021-11-03 The University of Kansas Inhibiteurs de hsp90 dérivés de biphénylamide
AU2015302633B2 (en) * 2014-08-13 2020-01-16 Meiji Seika Pharma Co., Ltd. Crystalline anti-trichophyton agents and preparation process thereof
CN106265640B (zh) * 2016-08-11 2019-05-14 吉林大学 Appa在制备治疗糖尿病肾病药物中的应用
CN108069831B (zh) * 2018-01-25 2020-11-24 上海恩氟佳科技有限公司 一种合成2,3-二甲基-4-氟苯酚的方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995011231A1 (fr) * 1993-10-21 1995-04-27 G. D. Searle & Co. Derives amidino utiles en tant qu'inhibiteurs de la synthase de l'oxyde nitrique
WO1996018616A1 (fr) * 1994-12-12 1996-06-20 Merck & Co., Inc. 2-aminopyridines substituees utilisees comme inhibiteurs de synthase d'oxyde d'azote

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994014780A1 (fr) * 1992-12-18 1994-07-07 The Wellcome Foundation Limited Derives de pyrimidine, de pyridine, de pteridinone et d'indazole utilises comme inhibiteurs enzymatiques
PT891332E (pt) * 1996-03-29 2004-07-30 Pfizer Derivados de 6-fenilpiridil-2-amina

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995011231A1 (fr) * 1993-10-21 1995-04-27 G. D. Searle & Co. Derives amidino utiles en tant qu'inhibiteurs de la synthase de l'oxyde nitrique
WO1996018616A1 (fr) * 1994-12-12 1996-06-20 Merck & Co., Inc. 2-aminopyridines substituees utilisees comme inhibiteurs de synthase d'oxyde d'azote

Also Published As

Publication number Publication date
TR199901917T2 (xx) 1999-12-21
DE69825147D1 (de) 2004-08-26
CZ292135B6 (cs) 2003-08-13
JP3505189B2 (ja) 2004-03-08
US20030162765A1 (en) 2003-08-28
NO993823D0 (no) 1999-08-09
CN1246848A (zh) 2000-03-08
TW458969B (en) 2001-10-11
AU5572798A (en) 1998-08-26
PT958282E (pt) 2004-11-30
SK101199A3 (en) 2000-10-09
NZ518345A (en) 2005-02-25
PE58599A1 (es) 1999-06-12
IL130898A0 (en) 2001-01-28
DZ2414A1 (fr) 2003-01-04
ATE271544T1 (de) 2004-08-15
JP2000509408A (ja) 2000-07-25
HRP980069A2 (en) 1998-12-31
EP0958282A1 (fr) 1999-11-24
TNSN98024A1 (fr) 2005-03-15
DE69825147T2 (de) 2005-08-04
EP0958282B1 (fr) 2004-07-21
GT199800032A (es) 1998-02-11
CO4920225A1 (es) 2000-05-29
BR9811093A (pt) 2000-07-18
DK0958282T3 (da) 2004-11-29
SI0958282T1 (en) 2005-02-28
ES2224354T3 (es) 2005-03-01
KR20000070803A (ko) 2000-11-25
EA003834B1 (ru) 2003-10-30
HN1998000030A (es) 1998-10-22
PL335161A1 (en) 2000-04-10
UA64740C2 (uk) 2004-03-15
YU35699A (sh) 2002-06-19
MY120976A (en) 2005-12-30
NZ336623A (en) 2000-11-24
IS5118A (is) 1999-07-29
AR011117A1 (es) 2000-08-02
NO993823L (no) 1999-08-09
US20010007873A1 (en) 2001-07-12
HUP0000762A2 (hu) 2000-09-28
CA2277990C (fr) 2006-08-01
CA2277990A1 (fr) 1998-08-13
CN1515554A (zh) 2004-07-28
MA27676A1 (fr) 2006-01-02
CZ276999A3 (cs) 2000-05-17
NO314803B1 (no) 2003-05-26
BG103633A (bg) 2000-11-30
EA199900632A1 (ru) 2000-02-28
PA8446301A1 (es) 2000-05-24
UY24881A1 (es) 2000-12-29
CN1523015A (zh) 2004-08-25
ZA981017B (en) 1999-08-10
OA11084A (en) 2002-03-15
HUP0000762A3 (en) 2000-10-30
AU744313B2 (en) 2002-02-21
KR100460399B1 (ko) 2004-12-08
WO1998034919A1 (fr) 1998-08-13

Similar Documents

Publication Publication Date Title
AP833A (en) 2-Amino-6-(2-substituted-4-phenoxy)-substituted-pyridines.
CA2302436C (fr) 2-aminopyridines alcoxy-substituees ramifiees
EP3658547B1 (fr) Procédé pour la préparation de n-(5-(4-(4-formyl-3-phényl-1h-pyrazol-1-yl)pyrimidin-2-ylamino)-4-méthoxy-2-morpholinophényl)acrylamide
MXPA01008671A (es) 2-aminopiridinas que contienen sustituyentes de tipo anillo condensado.
AU765851B2 (en) 2-aminopyridines containing fused ring substituents as nitric oxide synthase inhibitors
AU769233B2 (en) 2-amino-6-(2-substituted-4-phenoxy)-substituted-pyridines
US2759943A (en) Derivatives of 2-n-methyl-1, 2, 3, 4-tetrahydro-gamma-carbolines
MXPA99007398A (en) 2-amino-6-(2-substituted-4-phenoxy)-substituted-pyridines
EA007074B1 (ru) 2-амино-6-(2,4,5-замещенный фенил)пиридины для применения в качестве ингибиторов синтазы оксида азота
AU2017258665A1 (en) Process for the preparation of herbicidal compounds
US20040077853A1 (en) 2-amino-6-(2,4,5-substituted-phenyl)-pyridines
AU2002341234A1 (en) 2-amino-6-(2,4,5-substituted-phenyl)-pyridines for use as nitric oxide synthase inhibitors
MXPA00002028A (en) Branched alkoxy-subsituted 2-aminopyridines as nos inhibitors